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Abstract
Lymphatic filariasis (LF) is a debilitating disease caused by parasitic nematodes that affect
millions of people in largely tropical environments. While drugs are available for treating LF,
they suffer from a lack of efficacy against adult parasites, toxicity, and emergence of resistance.
Here, we describe two novel potential drug targets within the filarial parasite, Brugia malayi (B.
malayi). These two proteins, bm9350, a predictive MAPK stress response protein, and bm2032, a
potential histone modifying enzyme, have little or no annotation or experimental evidence of
function. Using predictive analysis and tools, we examined potential functions of these proteins
and their potential as anti-filarial drug targets.
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Introduction
Impact of Lymphatic filariasis
Lymphatic filariasis (LF) or elephantiasis, is a neglected tropical disease that can cause abnormal
swelling of the legs, arm, and genitalia (Figure 1)1–3. These disfigurations not only are painful
and run a high risk of infection, but are life-changing, leading to social and economic problems2.
Of the 120 million people
documented with LF in 2000,
40 million were diagnosed
with lymphedema or
elephantiasis1. Asymptomatic
Fig 1. Symptoms of lymphatic filariasis include swelling of limbs (as
pictured here)

infected individuals exhibit
compromised immune
responses and are susceptible
to a variety of secondary
infections. The impact of LF
is associated with an
estimated human burden of 8
million DALYs (disability

Fig 2. B. malayi lifecycle and infectious pattern

adjusted life years)4. A DALY
is the loss of productive years

due to ill health, death, or disability. LF is caused by infections of the parasitic nematodes
Wuchereria bancrofti (W. bancrofti), Brugia malayi (B. malayi), and Brugia timori (B. timori).
The parasite gains entry to the human body through a mosquito bite which introduces infected
L3 larvae. Once in the body, L3 larvae circulates in the blood and mature into adult worms
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which reside in the lymphatic system. Here, the worm will grow, mate, and release millions of
microfilaria which are then picked up by mosquito during a blood meal which then continues the
cycle1. The complete life cycle of B. malayi is shown in Figure 2.
Current treatments and the need for new drugs
In 2000, the WHO launched the Global Programme to Eliminate Lymphatic Filariasis (GPELF),
and their goal was to eliminate LF by 2020. To achieve this, a mass drug administration (MDA)
approach was used. This consisted of treatment with a variety of drugs, such as albendazole,
ivermectin and diethylcarbamazine (DEC). While these three medicines can clear almost all
microfiliaria from the blood in a few weeks, it does not eliminate the adult worms still in the
body. In order fully disrupt transmission of the disease, treatment must continue over several
years2. However, in 2017 it was predicted that many countries won’t meet this goal by 2020
using the current treatments available5. The limited number of drugs for treatment of LF are not
sufficient enough to eradicate this disease, being that they are not effective against all life stages
of the parasite, require annual and semi-annual treatments with possible side effects, as well as
drug-resistance is becoming apparent4. There is a need for anti-filarial drugs that kill the adult
parasites.
Current approaches being used to discover anti-filarial drugs is a combination of direct in vivo
phenotypic screening of compounds on target parasites, and compound screening on surrogate
organism models, e.g. C. elegans. However, these come with their own challenges, being that B.
malayi and other parasitic nematodes are limited to how long they can be cultured.
Also, high-throughput pharmaceutical research in parasitic nematode diseases that impact
humans has not been widely pursued6.
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One advance in identifying new drug targets in B. malayi was the sequencing of the genome
20107. While the genome has been sequenced, annotations on the predicted genes hasn’t been
completed in its entirety. This leaves a number of genes in the B. malayi genome with unknown

Figure 3: Current in silico methods to determine drug targets in B. malayi Genomic pooling of determined
essential genes from B. malayi compared to C. elegans were compared against human essential genes. The
genes that didn’t align with essential human genes were deemed the ‘target pool’ and were further analyzed as
potential drug targets. However, there are many unannotated B. malayi and C. elegans genes that may be
missing from this pool determined here due to a lack of annotation in the genomic and proteomic sequencing (4)

functions and therefore questioning their value as drug targets4.
The need for a new anti-filiarial drugs is crucial to eliminate LF. The focus in this thesis is on
two distinct proteins which may have the potential as drug targets for filariasis. The first is a
protein kinase that is part of a stress activated pathway related to the Bm-MPK1 pathway,
previously characterized in this laboratory, that is critical for Brugia malayi’s survival8. The
second is an epigenetic target previously identified in Schistomes that may be an important
potential target in anti-filiarial drug development9,10. In addition, we have identified a connection
between these two pathways that may have relevance in the drug discovery process.
I. Brugia malayi’s stress-induced pathway (MAPK pathway) and protein kinases
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B. malayi, once it infects a human, will primarily live in the lymphatics. In order to survive in the
human lymphatics, this nematode has developed a complex number of pathways to evade many
different stress activators that it must deal with, such as reactive oxygen species (ROS) generated
by innate immune responses8,11. In C. elegans, a critical pathway for coping with ROS involves a
protein kinase PMK-18. This protein exhibits high homology to a protein in B. malayi termed
Bm-MPK1. Using small molecule inhibitors of Bm-MPK1 it was determined that Bm-MPK1
functions in a signaling pathway that is crucial for a survival response against ROS8. The JNK
kinase pathway is a secondary stress-activated pathway related to the Bm-MPK1 pathway. B.
malayi expresses a JNK kinase ortholog, Bm-JNK (bm9350) which is similar to C. elegans kgb1, a constituent of a JNK kinase MAPK pathway in C. elegans12. Bm-JNK is further examined in
this thesis.
II. Histones and Histone modifying enzymes
The second potential target protein studied is a B. malayi histone demethylase enzyme. Histones
are important in gene regulation, as certain modifications can result in the tightening or
loosening of the chromatin structure, restricting or allowing for (respectively) transcription to
occur. There are four core histones, H2A, H2B, H3 and H4, that form an octamer which is
responsible for chromatin’s compact structure. Each of these core histones contain an N-terminal
tail that can be post-translationally modified12 (PTMs), which in turn modulate transcription.
These PTMs include, but are not limited to, acetylation and methylation of lysines (K) and
arginines (R). The lysines can be either mono-, di-, or tri- methylated, where the arginines can be
mono- or di- methylated13. There has also been evidence of peptide cleaving or hydroxylation at
specific residues which contain PTMs, adding further complexity to this matter14,15. It has been
found that methylation at H3K9, H3K27, and H4K20 resulted in repressed transcription.
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Conversely, it was found that methylation at H3K4, H3K36, and H3K79 were transcriptionally
active16. However, the complexity of these methylation patterns is increased due to more than
one methyl group being added to a residue18. Removal of histone methyl groups with subsequent
effects on transcription, is catalyzed by three different histone-specific demethylase families,
PADI4, LSD1, and JHDMs. The largest of these classes are the JHDMs demethylases, which are
responsible for demethylating H3K36, H3K9, and H3K36. The JHDM class of demethylases are
of considerable interest as drug target in various diseases, such as cancer17. For, example, it has
been shown that GSKJ4, an H3K27me3 demethylase inhibitor, suppresses proliferation of breast
cancer stem cells18.
Interestingly, it has been recently shown that GSKJ4 inhibits proliferation of Schistosoma
mansoni (S. mansoni) a trematode nematode, presumably inhibiting a S. mansoni demethylase9.
However, these enzymes have yet to be investigated in B. malayi as potential drug targets. From
the WormBase database, JmjC-domain containing proteins within the B. malayi genome were
identified. In particular, bm-jmjd5 or bm2032 is a gene in B. malayi that encodes for a B. malayi
demethylase. This thesis describes, through in silico methods, it’s functionality and potential as a
drug target.
Interaction of the JNK and demethylase pathways
Interestingly, a relationship between histone modifications and the MAPK pathway were
previously discovered in Listeria-infected endothelial cells19 as well as in human lung carcinoma
A549 cells20. While these two studies described different histone modifications, we also
examined the relationship these two pathways could have in B. malayi. Unexpectedly, we
discovered that by inhibiting demethylases in B. malayi, bm-JNK transcripts get upregulated. We
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believe this is indicative of a relationship between these two pathways which would be
interesting to explore in further studies.
Results
Bm-JNK
Sequence confirmation
ATGAGTTTTAATGCAAGTCTATTTCATCAAATTAAAGTGGAAGGACGCTCAACAGATGCT
TTATTTACTGTCCCCAAGCAATACACCAATCTTTCATATTTAAGTACCGGCGCTCAGGGA
ATTGTTGTTAAAGCTTATGATACGATTGCGCAAGAACAAGTTGCAATCAAAAAAATCATT
CATCCATTTCTGACAACAATGACCGCTCGTCGAACATATCGAGAATTTGTTTTGCTCACA
ACAATGAAACATCCAAATATAATACTGCTTAAAAATGCTTTTACGCCGCATAAATCATTG
GAAGATTTCGATGATATTTATGTAGTAATGGAATTAATGAATTATAATTTATCACAAGTG
ATTAAGCAACTAAAATTGGATAACAAAAATCTTTCATATTTTACGTATCAGATGATTGTT
GCAATTAAATATATGCATCGTAGTGGAATTATTCATCGGGATTTGAAGCCAAGTAATATA
GTAGTAAATGATAAATGCATTTTGAAAATACTTGATTTTGGATTAGCAAGAAAAATTGAA
ACAGGTGAACGTATGACTGTTTATGTTGTTACACGTTATTATCGTGCACCAGAAGTAATA
CTTGGTCTTCCATATGATGAAAAAGTTGATGTTTGGGCAATTGGATGCATATTAGCTGAA
ATGATAAATAGAAAAACTTTATTCCCGGGCACTGATCAACTTGATCAATGGAACAAAATT
ATTAAAATTTTGGGATCACCGAGCCAAGAATTTATTAATAAATTAGAACATCATACGAGA
AATTTTGTAAAAAGTAAGGGACACAATGATCCATTACCGTTTGAAGAAATTTTTCCAGAT
GAATGCTTTGTTGGAAATTATTCCAAAGCGCCACAACTTTGTGCTTCCGTTGCACGTGAT
TTGTTATTCAAAATGCTCCAAATTGATCCTGAAAAACGGATAAGTATTGATGAAGCAGTA
CGTCATCCATATGTAAATTTATGGTTTCGAGACGAGGAATGGAATGTACCACTTCCAGAA
AATCGTTATGATGCAAATAATGACCTTATCGATTTACCAATAAGTTCATGGAAAGAACTT
TTATTCAAAGAAGTGAAACGATGTGAGGAAGAACATTCATCAAAAAATACAAATTCCGAC
ATAATTAATAATTCTAAATGA
Figure 4: Bm9350 sequencing results: Truncated sequencing results, red text indicates full sequence from WormBase that
was not confirmed.

The long-term goal of this project is to express, purify, and examine functionality of the JNK
protein in B. malayi. WormBase is a database that provides information of genes, proteins,
expression patterns and much more for a variety of nematodes. However, working with genomic
sequences from a database, there has been uncertainty as to their accuracy21. Therefore, before
performing any analysis on this gene, the sequence from WormBase had to be confirmed
experimentally. Bm-JNK was truncated at the N and C terminus to make it easier to express and
purify, and therefore only this truncated protein sequence was confirmed (Figure 4). Being
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interested in a truncated protein, we were only able to confirm the regions that were picked up by
the primers designed for the truncated protein. From that analysis, it was determined that the
majority of bm-JNK’s sequence in Wormbase is accurate, as the sequencing results aligned
perfectly to the database for what we had expected of the truncated sequence.
Protein Expression Pattern
Bm-JNK expressed equally well in HEK-293XP cells over the course of 3 days (Figure 5).
However, being part of a phosphorylation cascade, the protein needs to be phosphorylated to
become “activated”. In order to investigate this cascade in B. malayi, extracts from treated
worms were western blotted and investigated for phosphorylated JNK protein (Figure 6). From
the results, it is shown that anisomycin and ionomycin
treatment results in higher quantities of phosphorylated
protein than the control. To see if stressors would also
activate the recombinant protein in HEK-293XP cells, the
HEK cells were treated with stressors that were known to
activate the MAPK pathway in humans: UV22,
Figure 5: Expression of bm9350
(JNK) over 3-day time course.

anisomycin23, and LPS24 (Figure 7). Interestingly, when
stressed, the HEK-293XP cells expressed the HIS tagged
protein poorly, and only faint bands of phosphorylated

Control | Aniso | Iono

threonine protein were found, and no phosphorylation was
P-JNK
Fig 6: Phosphorylation of JNK in B.
malayi stress treated extracts.
Imaged using anti-phospho-JNK
antibody.

determined for anti-tyrosine at the correct size. It was
suspected that the stressors were run at too high of a
concentration and ended up killing most of the HEK cells
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before collection. If run again in the future, the concentration of “stressors” used should be lower
and/or collected at a sooner timestamp.

Fig 7: Activation of bm9350 in HEK293 expi cells. Anti-phospho-threonine antibody
was used in the left image of this figure to determine phosphorylated (activated)
bm9350 protein. Anti-His antibody was used in the right image to determine total
expression of bm9350.

Proteomic analysis
First, to determine proteins with high similarity to bm-JNK, an NCBI BLAST program was run
against the bm-JNK protein sequence. The closest homolog in C. elegans was KGB-1 with a
55% identity. In order to determine similarities to the human proteome, delta blast was
performed again, except it was run against strictly the human proteome. The results from the
delta blast against human proteins showed that bm-JMJD5 matches closest (41.53% identity
covering 58% of the B. protein) with human JMJD5, which is also known as KDM8 (accession
Q8N371). Now knowing the highest similarity in proteins from humans and C. elegans, it was
further investigated whether the similaries were random or had some significance.
For bm-JNK, the results from the InterPro Domain search for itself and its C. elegans and human
homologs resulted in identical domains (Figure 8). While this will be useful for function
determination, it makes bm-JNK a harder drug target. Having similarity to a human protein
means that the drug developed will need to be further modified so that it only interacts with the
parasite and not interfere with the human protein. Therefore, the more similar the parasite protein
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Bm9350

a) Prot_kinase_dom 28-325 InterPro domain b) serkin_6 28-325 SMART c) Pkinase 29-325 Pfam d) Protein_kinase_dom 28-325
PROSITE profiles

ceKGB1

a) Prot_kinase_dom 38-338 InterPro domain b) Pkinase 42-338 Pfam c) serkin_6 38-338 SMART d) Protein_kinase_dom 38-338
PROSITE profiles

humanMAPK10

a) Prot_kinase_dom 64-359 InterPro domain b) Protein_kinase_domain 64-359 PROSITE profiles c) Pkinase 64-359 Pfam d) serkin_6
64-359 SMART

Fig 8: Interpro domain search results for bm9350, human MAPK10, and ceKGB-1. They all share the
same domains.

is to the human protein, the harder it is to achieve specificity. This is further exemplified by the
dot plots in Figure 9. For bm-JNK, the linearity with both C. elegans and human proteins show a
nearly linear pattern, with a few small breaks in the human dot plot and a small break in the C.
elegans dot plot.
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a)

b)

Fig 9: a) Dot plot of bm9350 v human MAPK10 b) Bm9350 v cekgb1 dot plot

Alignment analysis
While the domains provide a broad picture of similarity and function, a more specific approach
was also used. While B. malayi has little to no annotation performed on its proteome, C. elegans
and humans have experimental evidence to determine important residues for structure and
function. To see if these annotated residues aligned in the B. malayi protein, an alignment in
ClustalW was performed for each protein. The two bm-JNK alignments with MAPK10 from
humans and KGB-1 from C. elegans from humans Figure 10 and Figure 11 respectively. Both
alignments reveal inherit motifs that are known of protein kinases. These are the DFG, APE, and
HRD motifs, all of which are conserved in bm-JNK. The conservation of these motifs is
important in identifying this protein as a protein kinase. When looking closer at the alignment
between bm-JNK and human MAPK10, while the motifs were conserved, a region identified by
UNIPROT as the ATP nucleotide binding region has some discrepancy. This variation is also
seen in the alignment with KGB-1. While mostly being conserved, there are a few residues that
aren’t conserved. This could be indicative of an evolutionary mutation between organisms, or, a
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different mode of binding to ATP by the B. malayi protein. The ATP binding site and the proton
Bm9350
MAPK10

PKQYTNLSYLSTGAQGIVVKAYDTIAQEQVAIKKIIHPFLTTMTARRTYREFVLLTTMKH
LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH
*:* **. :.:****** ***:: :.:*****: :** .
*:*:***:**:. ::*

84
120

Bm9350
MAPK10

PNIILLKNAFTPHKSLEDFDDIYVVMELMNYNLSQVIKQLKLDNKNLSYFTYQMIVAIKY
KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-QMELDHERMSYLLYQMLCGIKH
*** * *.***:*:**:*:*:*:*****: **.*** *::**::.:**: ***: .**:

144
179

Bm9350
MAPK10

MHRSGIIHRDLKPSNIVVNDKCILKILDFGLARKIETGERMTVYVVTRYYRAPEVILGLP
LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG
:* :**************:..* **********. *. ** ***************:

204
239

Bm9350
MAPK10

YDEKVDVWAIGCILAEMINRKTLFPGTDQLDQWNKIIKILGSPSQEFINKLEHHTRNFVK
YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE
*.*:**:*::***:.**:.:* **** * :*****:*: **:*. **::**: .**:*:

264
299

Bm9350
MAPK10

SKGHNDPLPFEEIFPDECFVGNYSKAPQLCASVARDLLFKMLQIDPEKRISIDEAVRHPY
NRPKYAGLTFPKLFPDSLFPADS-EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY
.: :
* * ::***. * .: : :* ** ***** *** *** ****:*:*::***

324
358

Bm9350
MAPK10

VNLWFRDEEWNVPLPENRYDANNDLIDLPISSWKELLFKEVKRCEEEHSSKNTNSD---INVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPS
:*:*:
* :.* * : ** : * : *..****::*** ..**: .. .:.:

380
417

Bm9350
MAPK10

--IINNSK--------------------------------------GAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASAGPLGCCR
:*.*:

386
464

Fig 10: ClustalW alignment of bm9350 to human MAPK10 protein. Highlighted are regions from the
human protein that are annotated in literature to be important in structure and/or function. Red, green,
yellow, purple, and bold represent ATP binding, nucleotide binding, JNK motifs, activation sites, and
proton acceptor regions respectively.

accepting residues in human MAPK10 are conserved in bm-JMJD525. Interestingly, the
determined nucleotide binding region in MAPK1025 has a slight difference in B. malayi, possibly
indicating a different binding partner or binding in a slightly different fashion. This would be
interesting to further examine to see if this small discrepancy could be used as an advantage to
target the parasite’s protein more effectively.
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Bm9350
KGB1

--------MSFNASLFHQIKVEG--RSTDALFTVPKQYTNLSYLSTGAQGIVVKAYDTIA
MEVDLPVHNEYDASRFHQVTIRDPIAGADSTFTIPTRYVNLSFLNAGAQGTVVMADDLVT
.::** ***:.:..
.:*: **:*.:*.***:*.:**** ** * * ::

50
60

Bm9350
KGB1

QEQVAIKKIIHPFLTTMTARRTYREFVLLTTMKHPNIILLKNAFTPHKSLEDFDDIYVVM
TQRVAIKKMQQPFVMTMSAKRAYREFILLTTIKHPNIIRLLNAFTPDTSLSTFREVYLVM
::*****: :**: **:*:*:****:****:****** * *****..**. * ::*:**

110
120

Bm9350
KGB1

ELMNYNLSQVIKQLKLDNKNLSYFTYQMIVAIKYMHRSGIIHRDLKPSNIVVNDKCILKI
ELMTHNLHEVIHRLRLDHKTLSFFVYQSLCAIKHLHNSGVIHRDLKPSNIVVNDRCVLKV
***.:** :**::*:**:*.**:*.** : ***::*.**:**************:*:**:

170
180

Bm9350
KGB1

LDFGLARKI--ETGERMTVYVVTRYYRAPEVILGLPYDEKVDVWAIGCILAEMINRKTLF
LDFGLARKKNVDTSMRMSDYVVTRYYRAPEVILGLPYSEKVDIWSVGCIFAEMINHTVLF
********
:*. **: ******************.****:*::***:*****:..**

228
240

Bm9350
KGB1

PGTDQLDQWNKIIKILGSPSQEFINKLEHHTRNFVKSKGHNDPLPFEEIFPDECFVGNYS
PGKDRIDQWTKIYSVLGTPDDHFISQLGQSAAMYVRSLPRHQARAFSEIVPDTNFLPETE
**.*::***.** .:**:*.:.**.:* : : :*:* :::
*.**.** *: : .

288
300

Bm9350
KGB1

K-APQLCASVARDLLFKMLQIDPEKRISIDEAVRHPYVNLWFRDEEWNVPLPENRYDANN
NPRVHLTPHVARDLLFNMLKINPEERYSVEDALNHPYVKLWFKDDEVNAPASENRYDQEI
:
:*
*******:**:*:**:* *:::*:.****:***:*:* *.* ***** :

347
360

Bm9350
KGB1

DLIDLPISSWKELLFKEVKRCEEEHSSKNTNSDIINNSK
DFADKTLIEWKELIFNEVQRYQADHDIFTG--------*: * : .****:*:**:* : :*. .

386
390

Fig 11: Clustal W alignment of bm9350 to C. elegans KGB1. Red, blue, yellow, purple, and bold
highlighted regions represent ATP binding, nucleotide binding, JNK motifs, activation sites, and
proton acceptor regions respectively.

Isoforms
In B. malayi there is one isoform of bm-JNK, in C. elegans there is also one isoform of KGB-1,
and humans have 3 isoforms of MAPK10. The human isoforms only differ slightly in regions not
deemed crucial for function. However, it is interesting to note that while humans have more
isoforms of its protein kinase, the nematodes don’t. The relevance and importance of these
isoforms has not been investigated, however it is interesting to note these isoforms exist,
although the focus in this thesis is on the canonical sequences.
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Bm-JMJD5
Sequence Confirmation
For similar reasons described in the bm-JNK section, sanger sequencing was performed to
confirm the protein sequence from WormBase. From the Sanger sequence alignment with the
predicted genomic sequence from WormBase for bm-JMJD5, there were some small
discrepancies noticed. Upon further investigation into where these gaps were along the
sequencing results, it is important to note that the gaps weren’t in high quality regions, but
towards the end of the sequence where the quality was low (Figure 12). This led to the
conclusion that the although the gaps were in the sequencing results, it was due to low quality
reads towards the end of the sequencing run for that segment. Due to the nature of where the
gaps were and how small they were, it was assumed that the sequence in WormBase was the
correct sequence of the actual gene in the B. malayi nematode.
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a)

ATGATAGGATATGAAGTTACTATCCAAGATTTTGATGTATGGAAGGATGAAGGCTTGTTA
ACACAGTGTCGTTTGTTTTGTCGTGAAATATTCTGCCAAGAGTGCGGTTTACAGGAATTA
TCAGAAATTGATGCAGAGGATAGGAATAGTAGGCACATTGTGGTTCAGTTGACAGGTAAC
AACTCGGTGATCGGCATTTGTCGTCTACATTCCATCCAACCGTACATCAAGCTGGAGCAA
GTTGCTGTCCGCAAGGACTGGCGAGGACGAGCTATGGGGTATCGCCTATGTCGACGTGCT
ATAGAGTTAGCAGAATGTTTCTACAGTAGGCAAGTTCTGGTAACATATTCACACTACAGT
ACTGTAAAGTTTTACGAACAACTTGGCTTCATGGTAGCATCAGACGAATTTAGGGATGCT
GGTATTTTACATAAGACTATGTTTTATTTTCCACGTCGAAATAAGTTACCTACATTGCAT
TTGTGGAGATTTGACGATGCTGATTGTAAATATACACCAGGTGATTGCTTTGATCCGGCT
GTTATGGAGAGGATAAAAGAAACTATCATGTCATTCAAGGCACAAAACGTACCTAGACTA
GTGCATCTGCAACACTTGCCAGAAGAAAGTGTCGTTGGTTGTTCGCTAATTCGAATTAAT
TTTTTGGCGTCAATAGCGTGGGAAAAATTGAATACTGGCTATTATGAAGAGGTCGATGAA
GCTTGGAGAGTTTTTTACACAGTCATTATGATGTGTAGAGCAGTACGTTTGAAATTAGAG
AGACGAATAGAGGAAGCTTTGTTTGCTTGTGATATGGGTTTAATAATGGGTCGTGATGTT
GATGGTTTTGCGCTGTCGAACTTTGCTCATCATTTGCATGCTTCTTTATCAGAACCAACA
ACTCCTGTTTCTCTAAAA1ACTCAAAAGCTTTTGCAACCACCAGCTCCCTTACCGAACTCA
ATTTATGTTGATGTTTGCGAGCTACCATCGTTTGAAGAAATGTTAAAGATTATAAGAAAT
AAAAAACCAGTGGTCATACGAGGACTTGTAAATCAGTGGCCTGCATTTAGAAAATGGAAC
TTCTCATATTTCAACGAGCTTATTGGTCATCGTACAGTACCTATTGAAATTGGTAACAGT
TATGCCGATAGTGACTGGCAACAAGTTCTGATGACTTTTCGTACTTTCATTCAGAAATTC
ATAGAATGTGAGAACTCAGATGGTCCAGGTTATTTAGCACAACATCGGTTGTTTGATCAA
ATTCCAGAACTTTTGGATGATATTATAATTCCCGATTACTGTTCATTTGGTGAAGATGGG
CTTGACAATGTCGATATTAATATTTGGATTGGGCCATCAGGAACTGTATCACCTCTACAT
TTCGATCCAAAAAGTAACATGTTCTGCCAGGTGGTTGGCCGAAAGTTTTTACGTATAATA
CCTGCAACTGAAACTGAAAATGTGTACCCTCGACAGGATGGAATTTTGACCAACACCAGT
CAGATTGATGTACGAT2GTCCAGATTTGACAGAATTTCCACGTTTTCGCGAAGCTCATGTC
TTTGACTGTACATTGTATGCTGGTGATTGTTTGTTTATACCAGCTGGATTTTGGCATTAT

GTCTTCGCACTTGATCCGAGTATATCTGTGTCCTGTTGGTTCACTACCAAAATCT
AAA3
b)
1:

2:

3:

Figure 12: Sequencing results from bm2032. a) Final sequence determined from Sanger sequencing. Red
indicates gaps that were found in the sequence b) Gaps were determined to be not from the sequence itself
but from low quality reads at the ends of sequencing fragments
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Protein expression pattern
Having confirmed the sequence, a protein expression optimization was set up to determine the
best conditions to express bm-JMJD5. It was determined that the HIS tagged protein expressed
the highest when transformed into BL21 (DE3) Star cells and grown overnight at 25 ֯C before
induction (Figure 13). The purification process is currently underway.

Fig 13: Expression patter of bm2032 in BL21 (DE3) Star cells. Imaged using anti-6x his antibody.

Proteomic Analysis
Through the first analysis, it was found that bm-JMJD5 aligned with high conservation to many
other nematodes’ proteome. However, these matched proteins had little to no experimental
evidence, except for C. elegans JMJD5 protein, with 36.8% identity covering 96% of the B.
malayi protein. In order to determine similarities to the human proteome, delta blast was
performed again, except it was run against strictly the human proteome. Bm-JNK aligns highest
with human MAPK10, also known as JNK3 (accession P53779), with ~54% identity and
covering 91% of the B. malayi protein. While these percent identities seem low, I wanted to
investigate where these conserved amino acids were located in the protein and if they had any
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importance in structure and/or function. To do this, the first step was to perform a domain search
through InterPro.
As for bm-JMJD5, the results were more interesting (Figure 14). From the InterPro analysis of
the three homologous proteins, it was found that all share the JmjC domain. However, only bmJMJD5 and C. elegans JMJD5 share the GNAT domain towards the N-terminus, whereas the
human JMJD5 has no predictable domains in that region. This comparison becomes evident
when dot plots were formed between B. malayi and human versus B. malayi and C. elegans
(Figure 15). In the B. malayi and human dot plot, the plot only becomes linear with no gaps
around the 350 base region, which aligns with where the JmjC domain region begins. However,
in the B. malayi and C. elegans dot plot, the linearity is consistent from beginning to end with
small, minor gaps, indicating that ceJMJD5 is more closely related to bm-JMJD5 than the human
JMJD5. This makes sense being that the C. elegans and B. malayi are both nematodes and likely
evolved differently than humans. However, through this analysis we can learn a lot about the
potential function of bm-JMJD5 by comparing both C. elegans and human experimental
evidence. General control non-repressible 5 (GCN5)- related N-acetyltransferases (GNAT) are
enzymes that are responsible for transfering an acyl group from acyl coenzyme A (acyl-CoA) to
a substrate. The subtrates these enzymes transfer and acyl group to are highly diverse, making
their functions highly diverse also, being responsible for stress regulation, transcription control,
and a variety of other functions. There are more than 309,000 proteins with the GNAT domain
across all different organisms. Most GNAT enzymes share anywhere from 3%-23% sequence
identity and tend to vary significantly at the C-terminus but remain relatively conserved at the Nterminus of the protein. Structurally, length, number, and position of alpha-helices in these
enzymes are varied. This further adds to the point that GNAT enzymes are highly diverse in their
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Bm2032

a) GNAT_dom covering amino acids 6-152 from Interpro domains b) GNAT domain covering amino acids 6152 from PROSITE profiles c) Acetyltransf_10 domain covering amino acids 48-147 from Pfam d)
JmjC_domain covering amino acids 430-578 from Interpro e) Cupin_9 domain covering amino acids 430-577
from SMART f) JMJC domain covering amino acids 439-578 from PROSITE profiles g) Cupin_8 domain
covering amino acids 353-576 from InterPro h) Cupin_8 domain covering amino acids 353-576 from Pfam

Human JMJD5

a) JmjC_dom from residues 271-416 from InterPro domain b)JMJC covering residues 271-416 from PROSITE
profiles c) cupin_9 covering residues 271-416 from SMART d) cuping_8 covering residues 194-415 from
InterPRo domain e) Cupin_8 covering residues 194-415 from Pfam

C. elegans JMJD5

a) GNAT_dom covering amino acids 1-148 from InterPro domain b) GNAT covering amino acids 1-148 from
PROSITE profiles c) Acetyltransf_10 covering amino acids 14-133 from Pfam d) JmjC_dom covering residues
434-578 from InterPro domain e) JMJC covering residues 434-578 from PROSITE profiles f) cupin_9 covering
residues 434-578 from SMART g) Cupin_8 covering residues 366-578 from InterPro domain h) Cupin_8
covering resiudes 366-578 from Pfam
Figure 14: Domain matches from interpro for bm2032 (top) and human JMJD5 (middle) and c. elegans jmjd5
(bottom)

functionality, including their substrate specificity and different binding regions26. Generally, to
inhibit these proteins an acetyl-CoA analog is used, however, there are a variety of different
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molecules used to inhibit specific enzymes due to each enzyme’s specificity when it comes to
structure and function. This allows a lot of opportunity in a novel GNAT domain to develop a
compound that is specific to one GNAT enzyme.
To determine if the GNAT domain within B. malayi was an organism-specific domain, the
GNAT domain of bm-JMJD5 (base pairs 6 to 152) was run through NCBI’s BLAST algorithm
against the human proteome. Interestingly, no sequence similarity was found, making this
domain a potentially important region to target only B. malayi proteins and not human proteins.
Additionally, when B. malayi’s GNAT domain was run through the same algorithm, except
instead of against the human proteome it was run against nematodes, it was found that many
nematodes share this GNAT domain similarity. Specifically, nematodes such as W. bancrofiti, B.
timori, and Loa loa, which are common co-infectors, were part of this list (with 96.8% identity
and 100% coverage, 98.65 % identity and 50% coverage, and 66.45% identity and 100%
coverage).
Bm2032
a)

b)

Figure 15: a) Overall B. bm2032 v ce JMJD5 b) Overall B. bm2032 v human KDM8/JMJD5

While this isn’t the main focus of this thesis, it is important to note that these similarities make
bm-JMJD5 an interesting drug target because not only does it contain a domain not found in
humans that could be organism-specific, but this domain also shares similarities with other
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parasitic nematodes. Therefore, if a drug were found to target or disrupt this domain’s function,
then it could not only target B. malayi, but other co-infections in the patient, without targeting
the human proteins. This makes bm-JMJD5 a more promising drug target, being that if a drug
can target the GNAT domain specifically, it will potentially only bind to the B. malayi protein,
and not interfere with human proteins.
Alignment Analysis
While it is established that human JMJD5 and bm-JMJD5 have a highly conserved JMJC
domain, a further analysis into the individual amino acids that were determined crucial for
activity were conserved in B. malayi based on the ClustalW alignment (Figure 16).
Interestingly, the demethlyase activity of human JMJD5 is highly speculative, where some
papers confirm the activty of JMJD5 as a demethylase14,27,28 and others fail to reproduce their
data29 and suggest an alternative function as an H3 hydroxylase14,15,30,31. Del Rizzo et al.29
provides potential explations for this controversial evidence, suggesting that in vivo experiments
may allow the protein to form into a multimeric complex that allows the demethylase activity to
occur. Alternatively, this protein may be simply upregulating a demethylase as part of its
pathway, explaining why methylation statuses may change, while the enzyme itself lacks
intrinsic demethylase activity29. These are important to keep in mind while going through this
analysis and trying to uncover the function of bm-JMJD5.
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Fig 16: ClustalW alignment of bm2032 to human KDM8. Highlighted regions indicate important residues
determined experimentally for human JMJD5. Yellow highlighted regions correlate to residues important in
coordinating metal ion (Fe(II)). Green highlight recognizes residues responsible for 2-OG binding. Underlined
region is indicative of the predictive NLS sequence, where the bolded residues were determined critical for that
region. Residues highlighted in purple are indicative of regions where di-methyl arginine binding occurs. Red
highlighted residues were determined to be important for catalytic activity. If a residue has two colors, this
indicates it is multifunctional region.

It can be agreed upon by crystal structures of human JMJD5 that the Fe(II) metal ion is
coordinated by His-321, Asp-323, and His-400 (in B. malayi His-480, Asp-482, His-559)29,31. To
complete the octahedral coordination, a water molecule and 2-OG also are a part of this
interaction. 2-OG is also hydrogen bound to Tyr-272, Ser-318, Asn-327, and Lys-336 (in B.
malayi Tyr-431, Ser-477, Asn-486, Lys-495), with additional van der Waals interactions with
Trp-310, Leu-329, Val-402, and Trp-414 (in B. malayi Trp-469, Phe-488, Val-561, Trp-573)29. It
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is important to note that these residues all align in B. malayi, except for Leu-329 and Phe-488,
however, their structures are comparable and both able to perform the van der Waals
interactions. Bioinformatical analysis has shown that human JMJD5 clusters more closely with
hydroxylases than other lysine demethylases, further implicating KDM8 in hydroxylation rather
than demethylases. Interestingly though, in other hydroxylases, Trp-310, Ser-318, and Trp-414
are varied, indicating difference in substrates29. Being that bm-JMJD5 aligns and shows
conservation in these residues, human JMJD5 and bm-JMJD5 may share the same substrate,
which was identified as methylated H3K36me229.
To investigate the function of the N-terminus in human JMJD5, Huang et al performed a nuclear
localization signal (NLS) prediction using a computational mapping program to see if this region
is important for nuclear localization. They discovered a region from residues 152-170 that was
identified. While not entirely conserved in bm-JMJD5, it is important to note that Lys-166 and
Lys-167 (in B. malayi Leu-325 , Lys-326) were strictly conserved across all sequences when a
sequence comparison was performed across different species and, when mutated, completed
abolished nuclear localization32. Being that the functional amino acid is charged and the B.
malayi amino acid is not, this could mean that bm-JMJD5, if to have access to the nucleus, must
use a different method. The other critical residues in the human protein weren’t conserved as
well, and when mutated, decreased, but didn’t abolish, nuclear localization32. This indicates that
while not conserved perfectly with the human protein, this region could be important for nuclear
localization and is worth investigating further. To determine the substrate of human JMJD5,
crystal structures were formed with di- and mono-methylated arginine peptides. The methyl
groups of the di-methyl arginine were found “buried” in a negatively charged pocket that was
made up of Glu-238, Tyr-243, Tyr-272, Trp-248, Trp-310, Ser-318, (in B. malagi Glu-396 , Tyr-
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401 , Tyr-431,Trp- 406, Trp-469) and a portion of alpha-ketoglutarate. The monomethyl arginine
was in the same position, just lacking the second methyl group31.
In a mutational analysis of the alpha-ketoglutarate binging region, it was found that when Arg335 and Lys-336 (in B. malayi Arg-494, Lys-495) where mutated to Alanines, human JMJD5
lost its interaction with histone 3, however, when the Fe(II) coordinating region residues His-321
and Asp-323 (in B. malayi His-480, Asp-482) were mutated to Alanines, the protein was still
able to maintain histone 3 binding14. This indicates that Arg-335 and Lys-336 bind to Histone 3
without coordination of Fe(II) binding. These residues are conserved in bm-JMJD5, and it would
be interesting to see if this pattern is translational in future experimental studies.
From this alignment, important residues from UniProt in human JMJD5’s profile were
highlighted in Figure 16 above. Many of these functionally important residues align with bmJMJD5 indicating that the functions of JMJD5 and bm-JMJD5 may be similar. However, it is
important to note that the first 171 residues don’t align with JMJD5, and these residues contain
the GNAT domain, possibly implicating this protein in more than one function.
To further investigate bm-JMJD5’s GNAT domain, the 171 residues that make up this domain
were run through Wormbases’s BLAST program. The closest match was that from C. elegans,
JMJD5. From alignment analysis done previously, this protein has a higher homology to bmJMJD5 than human JMJD5, however, this protein is must less investigated. However, it was
found that when in C. elegans JMJD5, when His-484 and Asp-486 are mutated to Asn and
alanine respectively, levels of H3K36me2 were elevated. Additionally, these nematodes were
hypersensitive to IR33. These two residues are conserved in bm-JMJD5 as well (Figure 17), and
it would be interesting to see if this pattern is also seen in B. malayi in future experimental
studies. In the study done by Amendola et al.33 they attempted mutational studies within the
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GNAT domain, but failed to produce a mutated enzyme. This leaves the GNAT domain’s
function a mystery, only allowing speculation that these two proteins may be not only important
for H3K36 methylation regulation, but also responsible for acetylation of histones as well33.
Bm2032
Cejmjd5a

462
467

NVDINIWIGPSGTVSPLHFDPKSNMFCQVVGRKFLRIIPATETENVYPRQDGILTNTSQI
NVDMNMWIGPQDTVSPLHTDPRKNMFVQVHGTKLFRMVAPESSESVYP-FDGILSNTSQV
***:*:****..****** **:.*** ** * *::*::.. .:*.*** ****:****:

Fig 17: ClustalW alignment of bm2032 to C. elegans JMJD5. Yellow highlighted regions indicated mutational studies done
of the C. elegans JMJD5 protein that were determined to be important for H3K36me2 levels as well as sensitivity to IR.

Isoforms
Interestingly, while B. malayi only has a single isoform of its JMJD5 protein, C. elegans has two
isoforms, and humans have three. C. elegans have two isoforms of its JMJD5 protein, a and b.
The larger isoform includes the GNAT and JMJC domain and is 578 amino acids in length,
however, the second isoform (JMJD5 b) only includes the GNAT domain and is 190 amino acids
in length. While there haven’t been successful experiments examining the importance of this
GNAT domain, the evidence of the GNAT domain existing as an isoform is interesting and
demands more research to investigate. Looking at humans’ three isoforms of JMJD5, isoform 1
is described as the canonical sequence and is used in the analysis of this thesis. The largest of the
three is isoform 3. It has an additional thirty-nine amino acids at the beginning of the protein
when compared to the canonical sequence. Running this protein through Interpro gave no
additional domains or patterns, indicating that although expanding upon the beginning of the
protein, it adds no more annotation that could be detected by InterPro. The smallest isoform,
isoform 2, is missing residues 167-362 of the canonical sequence. These residues, however, do
not interfere with the JMJC domain of the protein. When run through InterPro, isoform 2 still
retains the JMJC and related cupin domains. Interestingly, this isoform has the JMJC domain
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starting at residue 42 and continuing to the end of the sequence, making this isoform strictly
composed of the JMJC domain, with no additional residues at the beginning.
Relationship between demethylase and the JNK pathway in B. malayi
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Fig 17: Expression of bm9350 and bm2032 in B. malayi
extracts under GSK-J4 treatment.

is a part of is regulating bmJMJD5 expression. GSK-J4 is a
known inhibitor of H3K27

(JMJD3)34 and was used to treat B. malayi worms for 4 and 8 hours. These treated worms were
collected and the expression pattern of both bm-JNK and bm-JMJD5 were investigated through
qPCR. Interestingly, it was found that in the treated GSK-J4 nematodes, there was no bm-JMJD5
expressed, however, bm-JNK was expressed. After 8 hours, the expression of bm-JNK increased,
where the expression of bm-JMJD5 remained suppressed entirely. This data is interesting;
however, it is hard to draw a conclusion from one trial, and there is no other evidence of these
two proteins being correlated.
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Discussion and Conclusions
From the predictive analysis done in this thesis, it is proposed that bm-JMJD5 and bm-JNK are
both valid and interesting potential drug targets for combating LF. However, due to the unique
nature of the GNAT domain within bm-JMJD5 makes it a more suitable drug target as
compounds can be developed for that domain that will be organism specific. Also, bm-JNK
requires an additional step where the protein needs to become “activated” to become functionally
active, where bm-JMJD5 does not require this step. This makes bm-JMJD5 an easier protein to
experimentally work with and examine. Bm-JMJD5 also has high similarity to other coinfectious nematodes with a similar GNAT domain. Therefore, pursuing bm-JMJD5 could also
benefit other infections as well as treat LF patients better. This being said, bm-JNK, although
having higher similarity to human protein MAPK10, still maintains some uniqueness in its
protein that is worth investigating and exploiting as a target. The benefit of bm-JNK is that its
implication in B. malayi’s survival in the lymphatic system has been explored and is known be a
part of a system that is crucial to the nematode’s survival in the human body. This has yet to be
explored for B. malayi with respect to bm-JMJD5. Interestingly, inhibiting one protein could lead
to a downstream effect as seen by the gene expression results. Using a known demethylase
inhibitor, GSKJ4, we have shown a doubling in expression of bm-JNK. We believe this is
indicative of a relationship between these two pathways which could be exploited downstream of
this drug discovery process.
While this thesis presents predictive work, it is important to confirm these predictions
experimentally. The beginning work of expressing and activating these proteins for experimental
studies has been described and the completion of these studies will be crucial in determining
their respective structures, functions, and eventually, druggability.
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Materials and Methods
B. malayi culturing in lab
B. malayi worms were received from the Filariasis Reacher Reagent Resource Center (FR3).
Upon arrival, tubes were sterilized with 70% ethanol and caps were opened slightly to allow
airflow into the tubes. They were then stored in an incubator under previously described35
conditions for 2 to 3 hours. Then, in a sterile hood, the worms were emptied into 5-mL wells and
each worm was transferred into their own 2-mL well in media previous described35. Once
separated, the worms were again placed into the incubator overnight and experiments were
performed the next day on the worms that survived the transferring process.
Sequencing
To get the sequence, first, RNA was extracted from the B. malayi nematode using the
RNAqueous-Micro Total RNA Isolation Kit from ThermoFisher Scientific. Once purified, the
RNA was converted to more stable cDNA TaaMan MicroRNA Reverse Transcription Kit from
ThermoFisher Scientific. Then, primers were designed such that the gene was split up into 4
small segments that overlapped. These primers were ordered from Invitrogen.
Bm2032 Primers:
F2032set1: ATGATAGGATATGAAGTTACTATC
R2032set1: CTTGAATGACATGATAGTTTCTTT
F2032set2: GCACAAAACGTACCTAGACTAG
R2032set2: TCACATTCTATGAATTTCTGAAT
F2032set3: ACTCAAAAGCTTTTGCAACCAC
R2032set3: CTGACTGGTGTTGGTCAAAATTC
F2032set4: CTTCTCATATTTCAACGAGCTTAT
R2032set4: TTAGATTTTGGTAGTGAACCAACA
Bm-9350 Primers:
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Bm9350F: TGGAAGGACGCTCAACAGAT
Bm9350R: CGAGCGGTCATTGTTGTCAG
Bm9350R1: GAATGTTCTTCCTCACATCG
Bm9350R2: TCATTTAGAATTATTAATTATGTCGG
Bm9350F: ATGAGTTTTAATGCAAGTCTATTTCAT

Then, a polymerase chain reaction was performed on purified RNA from the B. malayi parasite
and a PAGE (polyacrylamide gel electrophoresis) was run to ensure that the sequences were the
correct size and purity. Once confirmed, the PCR reaction was purified the Monarch PCR and
DNA Cleanup Kit, then submitted for Sanger Sequencing through Adam Parker at Montclair
State University. The sequencing primers were:
For bm2032:
Set1_REV_1: ATAGTCTTATGTAAAATACCAGCATCC
Short_FOR1: CTGCAACACTTGCCAGAAGA
Short_REV_1: CGCGTAAAATTTTGTGCTAAAG
Set2_REV_1: TGAGTTCGGTAAGGGAGCTG
Set2_FOR_1: TCATTTGCATGCTTCTTTATCA
Set3_FOR_1: TTTTGGATGATATTATAATTCCCG
Set3_REV_1: CTGATGGCCCAATCCAAATA
Set4_REV_1: TCTGGACATCGTACATCAATCTG
Set4_FOR_1: TACCTGCAACTGAAACTGAAAA
For bm9350:
Rev_2: ATCCAATTGCCCAACATCA
Rev_3: TCCGTTTTTCAGGATCAATTT
For_1: CCAAATATAATACTGCTTAAAAATGC
For_2: TGACTGTTTATGTTGTTACACGTT
For_3: GAAATTATTCCAAAGCGCCA
The sequences that came back were analyzed on Chromas 2.6.6. software, and then the
sequences from each Sanger output were aligned with the Bm2032 sequence from WormBase on
Clustal Omega.
In situ analysis
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To explore this protein as a potential drug target, BLAST (Basic Local Alignment Search Tool)
analysis was performed to compare the genomic and protein sequences of Bm2032 to other
organisms to analyze their active sites and important residues. The sequences from WormBase
were used for this analysis.
Then, to determine domains within the protein, InterPro domain search tool was used. Again, the
WormBase protein sequence was used.
To perform the alignment studies, the confirmed sequence of B. malayi’s protein from the lab
results were inputted into ClustalW along with the UniProt/WormBase sequence of the C.
elegans or human homolog.
Expression
Plasmid Preparation
Invitrogen provided both bm9350 and bm2032 in their respective plasmids. Bm9350 was
inserted into pEFbos plasmid and bm2032 was inserted into the Gateway system. The two
different plasmids, p17 (his tag protein) and p15 (GST tag protein), were utilized to optimize
tagging and growth of bm2032. Now in a plasmid, the gene of interest was transfected into
DH5alpha cells following standard protocol provided in kit and then stored O/N at 37C on
agarose plates spiked with 100 ug/mL kanamycin. Clones were selected and grown in 100 ug/mL
kanamycin agar O/N at 37C and 225 RPM. The overnight culture was then spun down at 5,000
RPM for 10 minutes and the pellet was rinsed with PBS. To extract the plasmid, the Qiagen
Midiprep Plasmid Extraction kit was used. The final concentration of plasmid was determined
via nano-drop and then stored in -20C for later use.
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For transfection of bm9350 plasmid into HEK293 Expi cells, previously described procedure36
was followed using the ExpiFcetamine 293 Transfection Kit from ThermoFisher Scientific. 1mL samples were collected in a sterile hood at 24, 48, and 72 hours post transfections. Samples
were spun down at 5,000xg for 10 minutes, supernatant was discarded, and pellet was stored in 20C freezer. These samples were examined through a Western Blot to determine optimal growth.
For transfection of bm2032 into protein expressing BL21 (DE3) Star competent cells, standard
procedure was followed according to One Shot BL21 Star (DE3) Chemically competent E. coli
Kit. Once a colony was selected from the O/N incubation of the BL21 (DE3) star cells, it was
placed in a 250-mL agarose broth with 100 ug/mL kanamycin and grown O/N at 25C. Then, 50mL of the O/N culture was placed in 200-mL fresh broth the next day at temperatures of 18C and
25C. Before induction, a 1-mL sample was collected and spun down at 5,000xg for 10 minutes,
and supernatant was discarded and the pellet stored at -20C. Then, the culture was induced with
100mM IPTG (for a final concentration of 0.1mM IPTG) and 1-mL samples were collected
immediately after induction, 2, 4, and 8 hours after induction. These samples were spun down at
5,000xg for 10 minutes, supernatant was discarded, and pellet was stored at -20C. These samples
were run on a western blot to examine protein optimization at different times before and after
induction as well as at different temperatures.
Stress Treatments for activated protein in B. malayi and HEK cells
To perform the stress treatments on HEK cell stress, it was decided upon UV, anisomycin, and
LPS treatments. The UV treatment was performed by placing the cells in the sterile hood and
turning on the UV light for 20 minutes. Before collecting, the cells were allowed to rest for 30
minutes. The anisomycin treatment consisted of a 100X concentration of anisomycin and was
allowed to sit for 30 minutes before collection of cells. For LPS stress treatment, 1.5 ug/mL of
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LPS was mixed into the cells and was mixed for 1 hour before collection of cells. To collect the
cells, centrifugation at 10,000 xg for 15 minutes was done, the supernatant discarded, and the
pellet rinsed with PBS solution.
To perform the stress treatments of B. malayi stress treatments, a group of 6 worms were placed
in a 5-mL well with appropriate media. Then, a 100X concentration of anisomycin or a 100X
concentration of ionomycin was mixed into the appropriate well for 30 minutes before collecting
An untreated control was also used in this experiment to compare results. To get worm protein
extracts, the worms were placed in Mammalian Protein Extraction Reagent (M-PER) from
ThermoFisher Scientific, pipetted into 1-mL tubes, and lysed on a Vortex Genie in a 4C
refrigerator for 45 minutes. Then, the tubes were spun down at 5,000xg for 15 minutes to allow
separation of cell debris from the lysing. The supernatant was collected and used for Western
Blot analysis.
qPCR
For the qPCR data, first, 16 B. malayi worms were treated with 100nM of the GSK-J4 drug.
Another 16 were untreated as the control. Then, after 4 hours, 8 of the GSK-J4 treated and 8 of
the untreated were collected as separate groups, rinsed with PBS buffer, and then lysed via bead
beating in RNA lysis buffer for 45 minutes in 4C refrigerator. Another group after 8 hours since
treatment was collected and treated the same way. Once fully lysed, the RNA was purified
following the procedures from the RNAqueous-Micro Total RNA Isolation Kit from
ThermoFisher Scientific. Once purified, the RNA was converted to more stable cDNA TaqMan
MicroRNA Reverse Transcription Kit from ThermoFisher Scientific. Then the qPCR was
performing using SYBR Green Real-Time PCR Kit from ThermoFisher Scientific. The
following primers were used for the qPCR:
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Bm2032 qPCR primers
F2032set2: GCACAAAACGTACCTAGACTAG
R2032set2: TCACATTCTATGAATTTCTGAAT
Bm9350 qPCR primers
Bm9350F: TGGAAGGACGCTCAACAGAT
Bm9350R: CGAGCGGTCATTGTTGTCAG
House-Keeping Gene (Actin)
Actin_left: TTGTCCAGATGAAGCACCAG
Actin_right: CGAACCGACGATGCATATAA

The qPCR was run and analysed in a StepOnePlus Real-Time PCR System from ThermoFisher
Scientific. To get the expression fold from the data output, the 2- ΔΔCT method was used as
described here37.
Western Blot
Western Blot analysis was performed following the procedures described here38. If protein
extraction was coming from E. coli, Bacterial Protein Expression Reagent (B-PER) was used to
lyse cells. If protein extraction was coming from B. malayi or HEK 293 expi cells, Mammalian
Protein Expression Reagent (M-PER) was used to lyse cells. The TrueBlack WB Blocking
Buffer Kit was used to perform western blots. The antibodies used to image the westerns were
anti-p-JNK (Millipore Sigma), anti-p-threonine (Millipore Sigma), and anti-6xhis (Millipore
Sigma). The secondary goat and rabbit antibodies were ordered from Millipore Sigma.
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